Guanfacine hydrochloride
CAS No. 29110-48-3
Guanfacine hydrochloride ( Guanfacine )
Catalog No. M13896 CAS No. 29110-48-3
A selective α2A receptor agonist that can reduce peripheral sympathetic outflow and thus cansues a reduction in peripheral sympathetic tone.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 42 | In Stock |
|
25MG | 70 | In Stock |
|
50MG | 126 | In Stock |
|
100MG | 203 | In Stock |
|
200MG | 311 | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGuanfacine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA selective α2A receptor agonist that can reduce peripheral sympathetic outflow and thus cansues a reduction in peripheral sympathetic tone.
-
DescriptionA selective α2A receptor agonist that can reduce peripheral sympathetic outflow and thus cansues a reduction in peripheral sympathetic tone; a sympatholytic agent used to treat hypertension and attention deficit hyperactivity disorder (ADHD).Hypertension Approved
-
SynonymsGuanfacine
-
PathwayAngiogenesis
-
TargetAdrenergic Receptor
-
Recptorα2A-adrenoceptor
-
Research AreaCardiovascular Disease
-
IndicationHypertension
Chemical Information
-
CAS Number29110-48-3
-
Formula Weight282.55
-
Molecular FormulaC9H10Cl3N3O
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 30 mg/mL
-
SMILESCl.NC(N)=NC(=O)CC1=C(Cl)C=CC=C1Cl
-
Chemical NameBenzeneacetamide, N-(aminoiminomethyl)-2,6-dichloro-, hydrochloride (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Midodrine hydrochlor...
Midodrine is a selective α1-adrenoceptor agonist that acts as a vasopressor/antihypotensive agent for the treatment of dysautonomia and orthostatic hypotension.
-
ARC 239 dihydrochlor...
A potent, selective α2B adrenoceptor antagonist with pKd of 8.8, 200-fold selectivity over α2A, and α2D receptors.
-
Dabuzalgron
Dabuzalgron is an orally active selective alpha-1A adrenergic receptor agonist used to treat urinary incontinence. Dabuzaron prevents cardiotoxicity caused by doxorubicin by maintaining mitochondrial function.Dabuzaron treatment increased ERK phosphorylation in a dose-dependent manner with an EC50 of 4.8 μM.